Psychiatry & Neurology, Sleep Medicine · Maitland, FL
NPI
1558378885
Since 2006
Specialty
Psychiatry & Neurology, Sleep Medicine
Code 2084S0012X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
557 N Wymore Rd Ste 202
Maitland, FL, 32751
Phone (407) 794-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$161K
1,774 services
Medicare patients, 2024
894
Average age 74
Drug cost, 2024
$40K
268 prescriptions
Company payments, 2025
$1,578
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karen M Baker was code 99214 (office e&m - established), 1,306 times for 761 patients. In total Karen M Baker billed 1,774 services in 7 codes, and Medicare paid $161K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,306 | 761 | $93.65 | $122K |
| 99204 Office E&M - New | Office | 139 | 139 | $110.84 | $15K |
| 95810 Sleep Study | Facility | 139 | 131 | $82.02 | $11K |
| 95811 Sleep Study | Facility | 49 | 47 | $82.16 | $4,026 |
| 95806 Sleep Study | Facility | 44 | 42 | $31.81 | $1,400 |
| 99213 Office E&M - Established | Office | 35 | 34 | $67.39 | $2,359 |
| 95806 Sleep Study | Office | 26 | 26 | $25.76 | $670 |
| 95810 Sleep Study | Office | 23 | 22 | $89.64 | $2,062 |
| 95811 Sleep Study | Office | 12 | 12 | $93.49 | $1,122 |
By year: 2022 $66K for 490 services; 2023 $41K for 478 services; 2024 $161K for 1,774 services.
Medicare prescription drug claims, 2024
In 2024, the drug Karen M Baker prescribed most often to Medicare patients was Zolpidem Tartrate, with 62 prescriptions and refills. In total Karen M Baker wrote 268 Medicare prescriptions that cost $40K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Zolpidem Tartrate Generic | 62 | 92 | 16 | $462 |
| Eszopiclone Generic | 38 | 38 | Under 11 | $548 |
| Modafinil Generic | 36 | 44 | Under 11 | $1,294 |
| Clonazepam Generic | 33 | 33 | Under 11 | $105 |
| Sunosi Solriamfetol Hcl | 23 | 23 | Under 11 | $19K |
| Armodafinil Generic | 14 | 14 | Under 11 | $1,342 |
| Doxepin Hcl Generic | 12 | 14 | Under 11 | $443 |
| Concerta Methylphenidate Hcl | 12 | 12 | Under 11 | $15K |
Brand drugs: 37 claims; generic drugs: 231 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karen M Baker $1,578 ($1,578 in general payments such as food, travel and fees) from 9 companies. The largest payer was Jazz Pharmaceuticals Inc. with $575.
| Company | Payments | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. JAZZ | 13 | $575 |
| Inspire Medical Systems, Inc. INSP | 6 | $456 |
| Axsome Therapeutics, Inc. AXSM | 11 | $157 |
| Harmony Biosciences LLC HRMY | 11 | $135 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $101 |
| Lilly USA, LLC LLY | 2 | $52.07 |
| Fisher & Paykel Healthcare Inc FPH.NZ | 2 | $47.17 |
| Resmed Corp RMD | 2 | $34.25 |
| ZOLL Respicardia, Inc. | 1 | $21.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.